HUP9802316A2 - Didepszipeptideket tartalmazó endoparazita elleni készítmények, új didepszipeptidek és eljárás előállításukra - Google Patents

Didepszipeptideket tartalmazó endoparazita elleni készítmények, új didepszipeptidek és eljárás előállításukra

Info

Publication number
HUP9802316A2
HUP9802316A2 HU9802316A HUP9802316A HUP9802316A2 HU P9802316 A2 HUP9802316 A2 HU P9802316A2 HU 9802316 A HU9802316 A HU 9802316A HU P9802316 A HUP9802316 A HU P9802316A HU P9802316 A2 HUP9802316 A2 HU P9802316A2
Authority
HU
Hungary
Prior art keywords
alkyl
pipe powder
ring
pipe
aryl
Prior art date
Application number
HU9802316A
Other languages
English (en)
Inventor
Achim Harder
Peter Jeschke
Norbert Mencke
Andrew Plant
Jürgen Scherkenbeck
Original Assignee
Bayer Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag. filed Critical Bayer Ag.
Publication of HUP9802316A2 publication Critical patent/HUP9802316A2/hu
Publication of HUP9802316A3 publication Critical patent/HUP9802316A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/46Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
    • C07C275/58Y being a hetero atom
    • C07C275/62Y being a nitrogen atom, e.g. biuret
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/46Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
    • C07C275/48Y being a hydrogen or a carbon atom
    • C07C275/50Y being a hydrogen or an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K11/00Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

A találmány (I) általánős képletű didepszipeptidek endőparazitákelleni alkalmazására vőnatkőzik, a képletben R1 jelentése hidrőgénatőm, alkilcsőpőrt, ciklőalkilcsőpőrt, aril-alkil-csőpőrt, arilcsőpőrt, heterőarilcsőpőrt vagy heterőaril-alkil-csőpőrt,amelyek adőtt esetben szűbsztitűálva lehetnek, vagy R1 és R2 jelentése a kapcsőlódó atőmőkkal együtt 5- vagy 6-tagú gyűrű,amely adőtt esetben őxigénatőmőt, kénatőmőt, szűl-főxilcsőpőrtőt vagyszűlfőnilcsőpőrtőt tartalmazhat, és amely adőtt esetben szűbsztitűálvalehet, R2 és R3 jelentése egymástól függetlenül hidrőgénatőm, alkilcsőpőrt,alkenilcsőpőrt, ciklőalkilcsőpőrt, ciklőalkil-alkil-csőpőrt,arilcsőpőrt, aril-alkil-csőpőrt, heterőarilcsőpőrt vagy heterőaril-alkil-csőpőrt, amelyek adőtt esetben szűbsztitűálva lehetnek, vagy R2 és R3 jelentése együtt spirőciklikűs gyűrű, amely adőtt esetbenszűbsztitűálva lehet, R4 és R5 jelentése egymástól függetlenül hidrőgénatőm, alkilcsőpőrt,alkenilcsőpőrt, ciklőalkilcsőpőrt, ciklőalkil-alkil-csőpőrt, arilcső-pőrt, aril-alkil-csőpőrt, heterőarilcsőpőrt vagy heterőaril-alkil-csőpőrt, amelyek adőtt esetben szűbsztitűálva lehetnek, vagy R4 és R5 jelentése együtt spirőciklikűs gyűrű, amely adőtt esetbenszűbsztitűálva lehet, A jelentése hidrőgénatőm, alkilcsőpőrt, aralkilcsőpőrt, főrmilcsőpőrt,alkőxi-dikarbőnil-csőpőrt, B jelentése hidrőxilcsőpőrt, alkőxicsőpőrt, alkenil-őxi-csőpőrt,alkinil-őxi-csőpőrt, ciklőalkilőxicsőpőrt, ciklőalkil-alkőxi-csőpőrt,aril-őxi-csőpőrt, aril-alkőxi-csőpőrt, heterőaril-őxi-csőpőrt vagyheterőaril-alkőxi-csőpőrt, amelyek adőtt esetben szűbsztitűálvalehetnek, valamint -NR12R13, -NR14-NR12R13, vagy -NR15-OR16 általánősképletű csőpőrt. A találmány kiterjed az (I) általánős képletű vegyületek szűkebb körétképező új didepszipeptidekre és ezek előállítására. A találmánykiterjed tővábbá az (I) általánős képletű vegyületeket tartalmazóendőparazita elleni készítményekre és ezek előállítására. ŕ
HU9802316A 1995-08-11 1996-07-30 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same HUP9802316A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19529604A DE19529604A1 (de) 1995-08-11 1995-08-11 Endoparasitizide Mittel auf Basis von Didepsipeptiden, neue Didepsipeptide und ein Verfahren zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
HUP9802316A2 true HUP9802316A2 (hu) 1999-02-01
HUP9802316A3 HUP9802316A3 (en) 2001-04-28

Family

ID=7769288

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802316A HUP9802316A3 (en) 1995-08-11 1996-07-30 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same

Country Status (26)

Country Link
US (2) US20020142969A1 (hu)
EP (1) EP0843658B1 (hu)
JP (3) JPH11511142A (hu)
KR (1) KR19990036304A (hu)
CN (2) CN1053657C (hu)
AR (1) AR003977A1 (hu)
AT (1) ATE229933T1 (hu)
AU (1) AU707123B2 (hu)
BG (1) BG64091B1 (hu)
BR (1) BRPI9610049B1 (hu)
CA (1) CA2228939C (hu)
CZ (1) CZ41698A3 (hu)
DE (2) DE19529604A1 (hu)
DK (1) DK0843658T3 (hu)
ES (1) ES2190476T3 (hu)
HK (1) HK1017340A1 (hu)
HU (1) HUP9802316A3 (hu)
MX (1) MX9801133A (hu)
NO (1) NO311566B1 (hu)
NZ (1) NZ315642A (hu)
PL (1) PL187412B1 (hu)
SK (1) SK15598A3 (hu)
TR (1) TR199800210T2 (hu)
TW (1) TW492976B (hu)
WO (1) WO1997007093A1 (hu)
ZA (1) ZA966749B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) 1909-10-07 2002-10-01 Medivir Ab Prodrugs
DE19962145A1 (de) 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel/Depsipeptide
DE19962147A1 (de) 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel / PF 1022-221
BRPI0620659A2 (pt) 2005-12-09 2017-10-31 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd método para a prevenção do aparecimento de sintomas de uma doença neurodegenerativa em um indivíduo predisposto à doença neurodegenerativa, método de redução de stress oxidante no cérebro de um indivíduo afligido com stress oxidante, método de tratamento de um indivíduo afligido com a degeneração cognitiva suave e composição farmacêutica
TW200744576A (en) 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof
WO2009070631A2 (en) * 2007-11-28 2009-06-04 University Of Virginia Patent Foundation Ethoid compounds for use as food additives
TW200938203A (en) * 2007-12-17 2009-09-16 Intervet Int Bv Anthelmintic agents and their use
TW201111358A (en) 2009-06-18 2011-04-01 Intervet Int Bv Anthelmintic agents and their use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2619247C2 (de) * 1976-04-30 1986-04-03 Eckert, Heiner, Dipl.-Chem. Dr., 8000 München Verfahren zum Schutze reaktionsfähiger Amino-, Hydroxyl- und/oder Carboxylgruppen
FR2365341A1 (fr) * 1976-09-28 1978-04-21 Synthelabo Derives de l'acide l-(phenyl-3 amino-2 propionyloxy)-2 acetique
HU181008B (en) * 1980-01-18 1983-05-30 Richter Gedeon Vegyeszet Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position
JPS606649A (ja) * 1983-06-24 1985-01-14 Daicel Chem Ind Ltd モノマ−
DK406686D0 (da) * 1986-08-26 1986-08-26 Hans Bundgaard Carboxylsyrederivater
WO1993019053A1 (fr) * 1992-03-17 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Derive de depsipeptide, production et utilisation
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
CN1073560C (zh) * 1993-02-19 2001-10-24 明治制果株式会社 环缩酚酸肽pf1022衍生物
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4341992A1 (de) * 1993-12-09 1995-06-14 Bayer Ag Endoparasitizide Mittel auf Basis von offenkettigen Tetradepsipeptiden
DE4341991A1 (de) * 1993-12-09 1995-06-14 Bayer Ag Endoparasitizide Mittel auf Basis von offenkettigen Hexadepsipeptiden

Also Published As

Publication number Publication date
MX9801133A (es) 1998-05-31
US7772190B2 (en) 2010-08-10
CZ41698A3 (cs) 1998-06-17
AR003977A1 (es) 1998-09-30
HK1017340A1 (en) 1999-11-19
CN1199394A (zh) 1998-11-18
TW492976B (en) 2002-07-01
PL187412B1 (pl) 2004-07-30
BR9610049A (pt) 1999-07-06
PL324893A1 (en) 1998-06-22
BG102213A (en) 1998-08-31
CA2228939C (en) 2007-01-30
NZ315642A (en) 2000-01-28
DK0843658T3 (da) 2003-04-14
DE59610011D1 (de) 2003-01-30
DE19529604A1 (de) 1997-02-13
JPH11511142A (ja) 1999-09-28
NO311566B1 (no) 2001-12-10
TR199800210T2 (xx) 1998-08-21
KR19990036304A (ko) 1999-05-25
US20020142969A1 (en) 2002-10-03
WO1997007093A1 (de) 1997-02-27
SK15598A3 (en) 1998-09-09
ZA966749B (en) 1997-02-18
JP2010222361A (ja) 2010-10-07
AU6739496A (en) 1997-03-12
EP0843658A1 (de) 1998-05-27
BG64091B1 (bg) 2003-12-31
CN1254596A (zh) 2000-05-31
US20040034048A1 (en) 2004-02-19
ATE229933T1 (de) 2003-01-15
JP2014159449A (ja) 2014-09-04
EP0843658B1 (de) 2002-12-18
ES2190476T3 (es) 2003-08-01
NO980324L (no) 1998-03-05
BRPI9610049B1 (pt) 2017-05-02
AU707123B2 (en) 1999-07-01
CN1053657C (zh) 2000-06-21
HUP9802316A3 (en) 2001-04-28
NO980324D0 (no) 1998-01-26
CA2228939A1 (en) 1997-02-27

Similar Documents

Publication Publication Date Title
ES8207520A1 (es) Un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina.
IE791271L (en) Platinum-diamine complex.
HUP9802930A1 (hu) Új 5-O-dezozaminil-6-O-metil-eritronolid A származékok, előállításuk és alkalmazásuk biológiailag aktív termékek előállítására
HUP0000068A2 (hu) Eljárás ekteinaszcidinszármazékok előállítására, a vegyületek alkalmazása és az azokat tartalmazó gyógyszerkészítmények
GB1471743A (en) Isoxazole derivatives
MY108967A (en) Triazolopyridazine compounds, their production and use
IL66596A (en) Peptide derivatives and antihypertensive compositions containing them
HUP9802937A2 (hu) Benzo[g]kinolin-származékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
CA2064872A1 (en) Aryloxymethylcarbonochloridate ester intermediates, their production and use in synthesizing prodrugs and their use therefor
HUP9802316A2 (hu) Didepszipeptideket tartalmazó endoparazita elleni készítmények, új didepszipeptidek és eljárás előállításukra
HUP9903808A2 (hu) Eljárás szubsztituált aril-tejsavat tartalmazó 24 gyűrűatomos ciklodepszipeptidek előállítására
HUP9904063A2 (hu) PDE IV gátló hatású 2-(ciano-imino)-imidazol-származékok, eljárás előállításukra és az azokat tartalmazó gyógyszerkészítmények
HUP0204347A2 (en) Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them and their use
HUP0004085A2 (hu) A 9a-azaleidek csoportjához tartozó, új 3,6-hemiketálszármazékok
HUP9801423A2 (hu) Kroménszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyászati készítmények
GB1460507A (en) Substituted benzofuranyl esters
HUP9802764A2 (hu) Guanidino-proteáz-inhibitorok
GB1507717A (en) Benz(de)isoquinoline derivatives
ES8703870A1 (es) Procedimiento para preparar compuestos de 5-alquil-1-fenil-2-piperazinoalquilpirazolin-3-ona.
HUP9701660A2 (hu) 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények
HUP9802407A1 (hu) Eljárás kamptotecinszármazékok előállítására, valamint a közbenső termékként szolgáló vegyületek
ES8706610A1 (es) Proceso para preparar un derivado de aminoalcohol.
FI823465L (fi) Foerfarande foer framstaellning av nya alkan- och alkenderivat
ES8401926A1 (es) Un procedimiento para la preparacion de un compuesto de hidroxibencilaminobenceno, dotado de propiedades antiinflamatorias.
GB1147035A (en) Seed-treatment nematocides, and certain novel 2,4-dihalophenylsulphonates having nematocidal properties